Medicis Pharmaceutical Corp. (MRX) Tops Q1 EPS by 14c
Tweet
Share
E-mailGet Alerts MRX Hot Sheet
Price: $71.99 -0.91%
Revenue Growth %: +21.2%
Financial Fact:
Research And Development Expense: 12.26M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: +21.2%
Financial Fact:
Research And Development Expense: 12.26M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Medicis Pharmaceutical Corp. (NASDAQ: MRX) reported Q1 EPS of $0.91, $0.14 better than the analyst estimate of $0.77. Revenue for the quarter came in at $467.3 million versus the consensus estimate of $428.46 million.
For earnings history and earnings-related data on Medicis Pharmaceutical Corp. (MRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paramount Weighs Tapping Musk For Equity Investment - Semafor
- IONQ Inc (IONQ) 5K contracts of September 25 weekly 45 calls as share price up 4.7%
- Cintas Corp. (CTAS) Tops Q1 EPS by 1c, Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
